Use of preclinical models to identify markers of type 2 diabetes susceptibility and novel regulators of insulin secretion - A step towards precision medicine.

Thorens B, Rodriguez A, Cruciani-Guglielmacci C, Wigger L, Ibberson M, Magnan C.

Open source

DOI
10.1016/j.molmet.2019.06.008
Published
2019-09-01
Container
Mol Metab
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.molmet.2019.06.008,
  title = {Use of preclinical models to identify markers of type 2 diabetes susceptibility and novel regulators of insulin secretion - A step towards precision medicine.},
  author = {Thorens B and  Rodriguez A and  Cruciani-Guglielmacci C and  Wigger L and  Ibberson M and  Magnan C.},
  year = {2019},
  journal = {Mol Metab},
  doi = {10.1016/j.molmet.2019.06.008},
  url = {https://doi.org/10.1016/j.molmet.2019.06.008}
}

RIS

TY  - JOUR
TI  - Use of preclinical models to identify markers of type 2 diabetes susceptibility and novel regulators of insulin secretion - A step towards precision medicine.
AU  - Thorens B
AU  -  Rodriguez A
AU  -  Cruciani-Guglielmacci C
AU  -  Wigger L
AU  -  Ibberson M
AU  -  Magnan C.
PY  - 2019
JO  - Mol Metab
DO  - 10.1016/j.molmet.2019.06.008
UR  - https://doi.org/10.1016/j.molmet.2019.06.008
ER  -

APA

B, T., A, R., C, C., L, W., M, I., & C., M. (2019). Use of preclinical models to identify markers of type 2 diabetes susceptibility and novel regulators of insulin secretion - A step towards precision medicine.. Mol Metab. https://doi.org/10.1016/j.molmet.2019.06.008

Source records